Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.

Gonzalez-Serna, AGenebat, MDe Luna-Romero, MTarancon-Diez, LDominguez-Molina, BPacheco, Y MMuñoz-Fernández, M ALeal, MRuiz-Mateos, E2023-01-252023-01-252016-09-23http://hdl.handle.net/10668/10329TROCAI is a phenotypic tropism test developed using the virological response to a short-term exposure to maraviroc monotherapy (Maraviroc Clinical Test [MCT]). It was found that with TROCAI, a cutoff ofenCyclohexanesHIVHIV Fusion InhibitorsHumansInhibitory Concentration 50MaravirocTriazolesViral TropismVirologyValidation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.research article27480849open access10.1128/AAC.01326-161098-6596PMC5038326https://europepmc.org/articles/pmc5038326?pdf=renderhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038326/pdf